🔎 Trials Near Me

Akèy › Maladi Alzheimer › Kalifòni › Irvine

Etid klinik pou Maladi Alzheimer nan Irvine, CA

11 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Irvine (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Ap rekriteFaz 4
  • Progeny Psychiatric Clinic - Irvine, Irvine
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470

A Study of LY3439539 in Participants With Alzheimer's Disease

Ap rekriteFaz 1
  • Irvine Clinical Research, Irvine
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2
  • Irvine Clinical Research, Irvine
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
  • Irvine Center for Clinical Research, Irvine
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Ap rekriteFaz 1/2
  • Irvine Center for Clinical Research /ID# 277752, Irvine
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Ap rekriteFaz 3
  • Irvine Clinical Research, Irvine
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Ap rekriteFaz 3
  • Irvine Center for Clinical Research, Irvine
Laj 55 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07717411

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Ap rekriteFaz 2
  • Irvine Clinical Research ( Site 1041), Irvine
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Ap rekriteFaz 3
  • Irvine Clinical Research, Irvine
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Ap rekriteFaz 2
  • Irvine Center for Clinical Research, Irvine
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

Biomarker Exploration in Aging, Cognition and Neurodegeneration

Ap rekriteFaz 3Volontè an sante akeyi
  • University of California, Irvine, Irvine
Laj 60 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT03860857

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan Irvine

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.